'Leap forward' in tailored cancer medicine

'Leap forward' in tailored cancer medicine People with untreatable cancers have had their immune system redesigned to attack their own tumours.

The experimental study involved only 16 patients, but has been called a "leap forward" and a "powerful" demonstration of the potential of such technology.

Each person had a treatment developed just for them, which targeted the specific weak spots in their tumour.

It is too early to fully assess the therapy's effectiveness and is expensive and time-consuming. BBC News

See also:

• Non-viral precision Tcell receptor replacement for personalized cell therapy (open access) Nature
• Silver bullet for cancer? Scientists use CRISPR to unlock patients' true tumor-fighting potential The Daily Mail